This inventor holds 1 USPTO granted patent. Top assignee: The Salk Institute. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations of Chandramouli Chiruta in Neuroprotective Compounds
Introduction
Chandramouli Chiruta is an accomplished inventor based in La Jolla, California. He has made significant contributions to the field of neuroprotective compounds, focusing on the development of synthetic analogs that offer various health benefits. His work is particularly relevant in the context of neurodegenerative diseases.
Latest Patents
Chiruta holds a patent for "Neuroprotective polyphenol analogs." This invention provides neuroprotective polyphenol compounds that can be synthetic analogs of fisetin, baicalein, or chlorogenic acid. These compounds maintain neuroprotective, anti-inflammatory, glutathione-promoting, and antioxidant properties. They are useful for promoting neuron protection, growth, and regeneration. Additionally, these polyphenol compounds can help increase and maintain intracellular glutathione (GSH) levels. They are also beneficial in treating, preventing, mitigating, and delaying various neurodegenerative conditions, including diabetes, Parkinson's disease, Huntington's disease, Alzheimer's disease, non-Alzheimer's dementias, multiple sclerosis, traumatic brain injury, spinal cord injury, and ALS. He has 1 patent.
Career Highlights
Chandramouli Chiruta is affiliated with the Salk Institute, a renowned research institution known for its innovative work in biological research. His role at the institute allows him to collaborate with leading scientists and contribute to groundbreaking research in neuroprotection.
Collaborations
Some of his notable coworkers include David R. Schubert and Pamela A. Maher. Their collaborative efforts enhance the research environment at the Salk Institute and contribute to advancements in neuroprotective therapies.
Conclusion
Chandramouli Chiruta's work in developing neuroprotective polyphenol compounds represents a significant advancement in the field of neurodegenerative disease research. His contributions have the potential to improve the quality of life for individuals affected by these conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile